| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | |||||||||
189,485 | 128,451 | 250,844 | 283,520 | 43,174 | 42,205 | 28,375 | 55,379 | 30,981 | 35,946 |
Short-term investments (note 5) | |||||||||
298,179 | 170,453 | 84,259 | 72,130 | 137,134 | 157,959 | 121,626 | 110,848 | 39,050 | 51,851 |
SR&ED receivables | |||||||||
- | - | 95 | 87 | 332 | - | 1,002 | 1,926 | 1,926 | 2,092 |
Accounts receivable | |||||||||
8,653 | 2,185 | 3,325 | 2,709 | 703 | 358 | 253 | 303 | 49 | 238 |
Prepaid expenses and other current assets | |||||||||
8,291 | 10,741 | 6,788 | 7,979 | 8,987 | 3,847 | 2,543 | 3,807 | 2,415 | 2,208 |
Total current assets | |||||||||
504,608 | 311,830 | 345,311 | 366,425 | 190,330 | 204,369 | 153,799 | 172,263 | 74,421 | 92,335 |
Deferred financing fees | |||||||||
590 | 650 | - | - | 366 | 265 | 181 | - | - | - |
Long-term investments (note 5) | |||||||||
75,758 | 0 | - | - | - | - | - | - | - | - |
Long-term prepaid assets | |||||||||
2,277 | 2,306 | 2,278 | 2,292 | 2,181 | 1,135 | 1,162 | 1,150 | 1,182 | 1,215 |
Deferred tax asset | |||||||||
459 | 1,218 | - | - | - | - | - | - | - | - |
Deferred tax asset (note 15) | |||||||||
- | - | 255 | 133 | 82 | 198 | 241 | 122 | 46 | 67 |
Property and equipment, net | |||||||||
11,032 | 11,100 | 10,148 | 8,482 | 6,262 | 6,484 | 6,385 | 6,752 | 6,949 | 7,178 |
Operating lease right-of-use assets | |||||||||
6,320 | 5,400 | 5,443 | 7,259 | 7,684 | - | - | - | - | - |
Intangible assets, net | |||||||||
5,890 | 6,057 | 6,958 | 312 | 962 | 1,614 | 2,260 | 296 | 528 | 748 |
Acquired in-process research and development (note 6) | |||||||||
17,628 | 17,628 | 17,628 | 17,628 | 18,396 | 18,396 | 18,396 | 18,396 | 18,396 | 18,396 |
Goodwill (note 6) | |||||||||
12,016 | 12,016 | 12,016 | 12,016 | 12,016 | 12,016 | 12,016 | 12,016 | 12,016 | 12,016 |
Total assets | |||||||||
636,578 | 368,205 | 400,037 | 414,547 | 238,279 | 244,477 | 194,440 | 210,995 | 113,538 | 131,955 |
Liabilities and shareholders’ equity | |||||||||
Current liabilities: | |||||||||
Accounts payable and accrued liabilities (note 7) | |||||||||
37,234 | 35,691 | 26,922 | 18,582 | 11,351 | 13,403 | 10,477 | 12,333 | 7,057 | 9,053 |
Warrant liabilities (note 9b) | |||||||||
- | - | - | - | - | - | - | - | 2,690 | 1,348 |
Fair value of liability classified options (note 12) | |||||||||
33,899 | 45,569 | 22,846 | 20,127 | 14,647 | 12,603 | 13,208 | 11,265 | 8,233 | 3,945 |
Current portion of operating lease liability (note 11) | |||||||||
1,749 | 1,282 | 912 | 1,669 | 1,655 | - | - | - | - | - |
Current portion of deferred revenue (note 13) | |||||||||
- | - | - | - | - | 3,530 | - | - | - | - |
Other current liabilities | |||||||||
23 | 10 | 9 | 14 | 503 | 450 | 277 | 147 | 205 | 315 |
Total current liabilities | |||||||||
72,905 | 82,552 | 50,689 | 40,392 | 28,156 | 29,986 | 23,962 | 23,745 | 18,185 | 14,661 |
Long-term portion of operating lease liability (note 11) | |||||||||
7,258 | 5,599 | 5,843 | 6,160 | 6,410 | - | - | - | - | - |
Long-term portion of deferred revenue (note 9) | |||||||||
32,941 | 32,941 | - | - | - | - | - | - | - | - |
Long-term portion of deferred revenue (note 13) | |||||||||
- | - | 32,941 | 32,941 | 32,941 | 32,941 | - | - | - | - |
Other long-term liabilities (note 7) | |||||||||
1,055 | 1,024 | 1,039 | 1,037 | 765 | 946 | 808 | 785 | 825 | 866 |
Deferred tax liability | |||||||||
0 | 408 | - | - | - | - | - | - | - | - |
Deferred tax liability (note 15) | |||||||||
- | - | - | - | - | 114 | - | - | - | - |
Total liabilities | |||||||||
114,159 | 122,524 | 90,512 | 80,530 | 68,272 | 63,987 | 24,770 | 24,530 | 19,010 | 15,527 |
Shareholders’ equity: | |||||||||
Common shares, no par value; unlimited authorized shares at March 31, 2020 and December 31, 2019, respectively; 45,533,201 and 39,564,529 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively (note 8b) | |||||||||
707,610 | 450,210 | 444,439 | 441,174 | 320,948 | 320,074 | 319,890 | 319,713 | 223,147 | 222,991 |
Additional paid-in capital | |||||||||
143,313 | 92,839 | 90,210 | 87,492 | 14,631 | 12,347 | 10,984 | 9,205 | 7,960 | 8,812 |
Accumulated other comprehensive loss | |||||||||
-6,659 | -6,659 | -6,659 | -6,659 | -6,659 | -6,659 | -6,659 | -6,659 | -6,659 | -6,659 |
Accumulated deficit | |||||||||
-321,845 | -290,709 | -218,465 | -187,990 | -158,913 | -145,272 | -154,545 | -135,794 | -129,920 | -108,716 |
Total shareholders’ equity | |||||||||
522,419 | 245,681 | 309,525 | 334,017 | 170,007 | 180,490 | 169,670 | 186,465 | 94,528 | 116,428 |
Total liabilities and shareholders’ equity | |||||||||
636,578 | 368,205 | 400,037 | 414,547 | 238,279 | 244,477 | 194,440 | 210,995 | 113,538 | 131,955 |